Cabaletta Bio Inc
Biotechnology
Healthcare
CABA
49.47 M shares
NASDAQ US
traded
31 Mar 2025
listed
no
open
1.48
52 week high
12.88
high
1.51
52 week low
1.39
low
1.36
growth
-87.66 %
previous Close
1.55
P/E ratio
market cap
115 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-30.63 M
-10.97 %
eps
0.00 %
-10.71 %
eps surprise
-3.33 %
net profit margin
-3062900000.00 %
0.00 %
operating incoming
-33.05 M
-9.14 %
net change in cash
-8.01 M
-341.11 %
cash on hand
171 M
-4.48 %
cost of revenue
0.00 %
top top